Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 627

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Ferritin for the clinician

Open access
Knovich, Mary Ann, Storey, Jonathan A., Coffman, Lan G., Torti, Suzy V., Torti, Frank M.·2009·Blood Reviews
DOI 10.1016/j.blre.2008.08.001
Open this paper in CoChat — free account

Abstract

Ferritin, a major iron storage protein, is essential to iron homeostasis and is involved in a wide range of physiologic and pathologic processes. In clinical medicine, ferritin is predominantly utilized as a serum marker of total body iron stores. In cases of iron deficiency and overload, serum ferritin serves a critical role in both diagnosis and management. Elevated serum and tissue ferritin are linked to coronary artery disease, malignancy, and poor outcomes following stem cell transplantation. Ferritin is directly implicated in less common but potentially devastating human diseases including sideroblastic anemias, neurodegenerative disorders, and hemophagocytic syndrome. Additionally, recent research describes novel functions of ferritin independent of iron storage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.blre.2008.08.001

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 86

  1. Andrews, 2007, Iron homeostasis, Annu Rev Physiol, 69, 69, 10.1146/annurev.physiol.69.031905.164337 · DOI · Paper page
  2. Andrews, 2005, Understanding heme transport, N Engl J Med, 353, 2508, 10.1056/NEJMcibr053987 · DOI
  3. Anderson, 2005, Hepatic iron metabolism, Semin Liver Dis, 25, 420, 10.1055/s-2005-923314 · DOI
  4. Heeney, 2004, Iron homeostasis and inherited iron overload disorders: an overview, Hematol Oncol Clin North Am, 18, 1379, 10.1016/j.hoc.2004.06.018 · DOI
  5. Ohgami, 2006, The Steap proteins are metalloreductases, Blood, 108, 1388, 10.1182/blood-2006-02-003681 · DOI · Paper page
  6. Roy, 2005, Anemia of inflammation: the hepcidin link, Curr Opin Hematol, 12, 107, 10.1097/00062752-200503000-00001 · DOI
  7. Taketani, 2005, Acquisition, mobilization and utilization of cellular iron and heme: endless findings and growing evidence of tight regulation, Tohoku J Exp Med, 205, 297, 10.1620/tjem.205.297 · DOI
  8. Finch, 1986, Plasma ferritin determination as a diagnostic tool, West J Med, 145, 657
  9. Hallberg, 1993, Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women, Br J Haematol, 85, 787, 10.1111/j.1365-2141.1993.tb03225.x · DOI
  10. Weiss, 2005, Modification of iron regulation by the inflammatory response, Best Pract Res Clin Haematol, 18, 183, 10.1016/j.beha.2004.09.001 · DOI · Paper page
  11. Kalantar-Zadeh, 2006, The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?, Clin J Am Soc Nephrol, 1, S9, 10.2215/CJN.01390406 · DOI
  12. Coyne, 2006, Iron indices: what do they really mean?, Kidney Int Suppl, S4, 10.1038/sj.ki.5000404 · DOI
  13. Wish, 2006, Assessing iron status: beyond serum ferritin and transferrin saturation, Clin J Am Soc Nephrol, 1, S4, 10.2215/CJN.01490506 · DOI · Paper page
  14. Guyatt, 1992, Laboratory diagnosis of iron-deficiency anemia: an overview, J Gen Intern Med, 7, 145, 10.1007/BF02598003 · DOI · Paper page
  15. Allen, 2008, Iron-overload-related disease in HFE hereditary hemochromatosis, N Engl J Med, 358, 221, 10.1056/NEJMoa073286 · DOI · Paper page
  16. Bacon, 2008, Clinical penetrance of hereditary hemochromatosis, N Engl J Med, 358, 291, 10.1056/NEJMe078215 · DOI
  17. Qaseem, 2005, Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians, Annu Intern Med, 143, 517, 10.7326/0003-4819-143-7-200510040-00010 · DOI
  18. Waalen, 2008, Screening for hemochromatosis by measuring ferritin levels: a more effective approach, Blood, 111, 3373, 10.1182/blood-2007-07-102673 · DOI
  19. Gordeuk, 1992, Iron overload in Africa. Interaction between a gene and dietary iron content, N Engl J Med, 326, 95, 10.1056/NEJM199201093260204 · DOI · Paper page
  20. Maggio, 2007, Light and shadows in the iron chelation treatment of haematological diseases, Br J Haematol, 138, 407, 10.1111/j.1365-2141.2007.06666.x · DOI
  21. Barton, 2007, Optimal management strategies for chronic iron overload, Drugs, 67, 685, 10.2165/00003495-200767050-00004 · DOI
  22. Porter, 2005, Monitoring and treatment of iron overload: state of the art and new approaches, Semin Hematol, 42, S14, 10.1053/j.seminhematol.2005.01.004 · DOI
  23. Magri, 2008, Early impairment of myocardial function in young patients with beta-thalassemia major, Eur J Haematol, 80, 515, 10.1111/j.1600-0609.2008.01054.x · DOI
  24. Stumpf, 2007, Deferasirox, Am J Health Syst Pharm, 64, 606, 10.2146/ajhp060405 · DOI
  25. Cook, 2003, The quantitative assessment of body iron, Blood, 101, 3359, 10.1182/blood-2002-10-3071 · DOI · Paper page
  26. Sheth, 2005, Methods for noninvasive measurement of tissue iron in Cooley’s anemia, Ann N Y Acad Sci, 1054, 358, 10.1196/annals.1345.044 · DOI
  27. Wood, 2007, Magnetic resonance imaging measurement of iron overload, Curr Opin Hematol, 14, 183, 10.1097/MOH.0b013e3280d2b76b · DOI
  28. Wood, 2005, MRI R2 and R2∗ mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients, Blood, 106, 1460, 10.1182/blood-2004-10-3982 · DOI · Paper page
  29. Anderson, 2001, Cardiovascular T2-star (T2∗) magnetic resonance for the early diagnosis of myocardial iron overload, Eur Heart J, 22, 2171, 10.1053/euhj.2001.2822 · DOI · Paper page
  30. St Pierre, 2005, Measurement and mapping of liver iron concentrations using magnetic resonance imaging, Ann N Y Acad Sci, 1054, 379, 10.1196/annals.1345.046 · DOI
  31. St Pierre, 2005, Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance, Blood, 105, 855, 10.1182/blood-2004-01-0177 · DOI · Paper page
  32. Carneiro, 2005, Liver iron concentration evaluated by two magnetic methods: magnetic resonance imaging and magnetic susceptometry, Magn Reson Med, 54, 122, 10.1002/mrm.20510 · DOI
  33. Zandman-Goddard, 2007, Ferritin in autoimmune diseases, Autoimmun Rev, 6, 457, 10.1016/j.autrev.2007.01.016 · DOI
  34. Uppal, 2007, Ten years of clinical experience with adult onset Still’s disease: is the outcome improving?, Clin Rheumatol, 26, 1055, 10.1007/s10067-006-0440-x · DOI
  35. Evensen, 2007, Increased ferritin response in adult Still’s disease: specificity and relationship to outcome, Scand J Rheumatol, 36, 107, 10.1080/03009740600958504 · DOI
  36. Sekigawa, 2001, Hemophagocytosis in autoimmune disease, Clin Exp Rheumatol, 19, 333
  37. Emmenegger, 2005, Haemophagocytic syndromes in adults: current concepts and challenges ahead, Swiss Med Wkly, 135, 299
  38. Emmenegger, 2001, Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes, Am J Hematol, 68, 4, 10.1002/ajh.1141 · DOI
  39. Cazzola, 2003, Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia, Blood, 101, 1996, 10.1182/blood-2002-07-2006 · DOI
  40. la Porta, 2006, Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome, Leukemia, 20, 549, 10.1038/sj.leu.2404142 · DOI
  41. Jaffe ES, 1943-World Health Organization. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; Oxford: Oxford University Press (Distributor); 2001.
  42. Haddad, 2008, Hypocupremia and bone marrow failure, Haematologica, 93, e1, 10.3324/haematol.12121 · DOI
  43. Thomas, 2004, Neurodegenerative disease and iron storage in the brain, Curr Opin Neurol, 17, 437, 10.1097/01.wco.0000137534.61244.d1 · DOI
  44. Madsen, 2007, Copper and iron disorders of the brain, Annu Rev Neurosci, 30, 317, 10.1146/annurev.neuro.30.051606.094232 · DOI · Paper page
  45. Gotz, 2004, The relevance of iron in the pathogenesis of Parkinson’s disease, Ann N Y Acad Sci, 1012, 193, 10.1196/annals.1306.017 · DOI · Paper page
  46. Zecca, 2005, In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage, Mov Disord, 20, 1278, 10.1002/mds.20550 · DOI · Paper page
  47. Hirsch, 1994, Biochemistry of Parkinson’s disease with special reference to the dopaminergic systems, Mol Neurobiol, 9, 135, 10.1007/BF02816113 · DOI
  48. Waldvogel, 1999, Increased iron in the dentate nucleus of patients with Friedreich’s ataxia, Ann Neurol, 46, 123, 10.1002/1531-8249(199907)46:1<123::AID-ANA19>3.0.CO;2-H · DOI
  49. Boddaert, 2007, Selective iron chelation in Friedreich Ataxia: biologic and clinical implications, Blood, 110, 401, 10.1182/blood-2006-12-065433 · DOI · Paper page
  50. Levi, 2005, Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation, Best Pract Res Clin Haematol, 18, 265, 10.1016/j.beha.2004.08.021 · DOI
  51. Kotagal, 2004, Childhood-onset restless legs syndrome, Ann Neurol, 56, 803, 10.1002/ana.20292 · DOI
  52. Hogl, 2005, Restless legs syndrome: a community-based study of prevalence, severity, and risk factors, Neurology, 64, 1920, 10.1212/01.WNL.0000163996.64461.A3 · DOI · Paper page
  53. Earley, 2000, Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome, Neurology, 54, 1698, 10.1212/WNL.54.8.1698 · DOI · Paper page
  54. Connor, 2003, Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome, Neurology, 61, 304, 10.1212/01.WNL.0000078887.16593.12 · DOI · Paper page
  55. Bonneau, 1995, Bilateral cataract and high serum ferritin: a new dominant genetic disorder?, J Med Genet, 32, 778, 10.1136/jmg.32.10.778 · DOI
  56. Girelli, 1995, Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the “Verona mutation”), Blood, 86, 4050, 10.1182/blood.V86.11.4050.bloodjournal86114050 · DOI · Paper page
  57. Bonneau, 1995, Bilateral cataract and high serum ferritin: a new dominant genetic disorder?, J Med Genet, 32, 778, 10.1136/jmg.32.10.778 · DOI
  58. You, 2005, Ferritin in atherosclerosis, Clin Chim Acta, 357, 1, 10.1016/j.cccn.2005.02.001 · DOI
  59. de Godoy, 2007, Serum ferritin and obstructive coronary artery disease: angiographic correlation, Arq Bras Cardiol, 88, 430
  60. Klipstein-Grobusch, 1999, Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study, Am J Clin Nutr, 69, 1231, 10.1093/ajcn/69.6.1231 · DOI
  61. Tuomainen, 1997, Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland, BMJ, 314, 793, 10.1136/bmj.314.7083.793 · DOI
  62. Liu, 2005, Ferritin as an iron concentrator and chelator target, Ann N Y Acad Sci, 1054, 136, 10.1196/annals.1345.016 · DOI
  63. Kabat, 2007, Does excess iron play a role in breast carcinogenesis? an unresolved hypothesis, Cancer Causes Control, 18, 1047, 10.1007/s10552-007-9058-9 · DOI
  64. Elliott, 1993, Breast carcinoma and the role of iron metabolism. A cytochemical, tissue culture, and ultrastructural study, Ann N Y Acad Sci, 698, 159, 10.1111/j.1749-6632.1993.tb17204.x · DOI
  65. Weinstein, 1982, Tissue ferritin concentration in carcinoma of the breast, Cancer, 50, 2406, 10.1002/1097-0142(19821201)50:11<2406::AID-CNCR2820501127>3.0.CO;2-S · DOI
  66. Marcus, 1975, Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer, J Nat Cancer Inst, 55, 791, 10.1093/jnci/55.4.791 · DOI
  67. Rossiello, 1984, Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue, J Clin Pathol, 37, 51, 10.1136/jcp.37.1.51 · DOI · Paper page
  68. Ionescu, 2006, Increased levels of transition metals in breast cancer tissue, Neuro Endocrinol Lett, 27 Suppl. 1, 36
  69. Buss, 2003, The role of iron chelation in cancer therapy, Curr Med Chem, 10, 1021, 10.2174/0929867033457638 · DOI
  70. Armand, 2007, Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation, Blood, 109, 4586, 10.1182/blood-2006-10-054924 · DOI · Paper page
  71. Lucarelli, 1990, Bone marrow transplantation in patients with thalassemia, N Engl J Med, 322, 417, 10.1056/NEJM199002153220701 · DOI · Paper page
  72. Storey, 2007, The transfusion iron overload score is a potential predictor of survival in stem cell transplant patients, Blood, 110, 336A, 10.1182/blood.V110.11.1108.1108 · DOI
  73. Armand, 2007, Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation, Blood, 109, 4586, 10.1182/blood-2006-10-054924 · DOI · Paper page
  74. Altes, 2002, Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation, Bone Marrow Transplant, 29, 987, 10.1038/sj.bmt.1703570 · DOI
  75. Altes, 2004, Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis, Bone Marrow Transplant, 34, 505, 10.1038/sj.bmt.1704628 · DOI
  76. Altes, 2007, Early clinical impact of iron overload in stem cell transplantation. A prospective study, Ann Hematol, 86, 443, 10.1007/s00277-007-0266-x · DOI
  77. Lucarelli, 1993, Marrow transplantation in patients with thalassemia responsive to iron chelation therapy, N Engl J Med, 329, 840, 10.1056/NEJM199309163291204 · DOI · Paper page
  78. Massover, 1994, Alpha 2-macroglobulin: a ferritin-binding protein, Ann N Y Acad Sci, 737, 468, 10.1111/j.1749-6632.1994.tb44342.x · DOI
  79. Seki, 2008, Apolipoprotein B binds ferritin by hemin-mediated binding: evidence of direct binding of apolipoprotein B and ferritin to hemin, Biometals, 21, 61, 10.1007/s10534-007-9093-8 · DOI
  80. Torti, 1998, Human H-kininogen is a ferritin-binding protein, J Biol Chem, 273, 13630, 10.1074/jbc.273.22.13630 · DOI
  81. Schmaier, 2007, The plasma kallikrein-kinin system: its evolution from contact activation, J Thromb Haemost, 5, 2323, 10.1111/j.1538-7836.2007.02770.x · DOI
  82. Barnes, 1992, Effect of bradykinin on airway function, Agents Actions Suppl, 38, 432
  83. Sainz, 2007, Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo pathophysiology, Thromb Haemost, 98, 77, 10.1160/TH07-04-0250 · DOI
  84. Stewart, 2005, Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists, Peptides, 26, 1288, 10.1016/j.peptides.2005.03.052 · DOI
  85. Parthasarathy, 2002, Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release, Biochem J, 365, 279, 10.1042/bj20011637 · DOI
  86. Coffman, 2008, Cleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritin, Am J Physiol Lung Cell Mol Physiol, 294, L505, 10.1152/ajplung.00347.2007 · DOI

Cited by

See all 627

Metadata

Authors
Knovich, M. A., Storey, J. A., Coffman, L. G., Torti, S. V., & Torti, F. M.
Venue
Blood Reviews
Publisher
Elsevier BV
Published
2009-05
Volume
23
Issue
3
Pages
95-104
ISSN
0268-960X (ISSN-L)
DOI
10.1016/j.blre.2008.08.001
OpenAlex
W2157296374
Cited by
627
References
8
FWCI
8.20
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ferritin for the clinician. https://app.cochat.ai/papers/10.1016/j.blre.2008.08.001
The paper
Knovich, M. A., Storey, J. A., Coffman, L. G., Torti, S. V., & Torti, F. M. (2009). Ferritin for the clinician. Blood Reviews. https://doi.org/10.1016/j.blre.2008.08.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.